NADPH Oxidase Nox4 Regulates the Protective Effect of Fenofribate Against Cardiac Hypertrophy
CSTR:
Author:
Affiliation:

1.Guangdong No.2 Provicial People’s Hospital, Guangzhou, Guangdong 510317;2.Sun Yat-sen University, Guangzhou, Guangdong 510000;3.The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Aim To elucidate the relation between NADPH oxidase Nox4 and the protective effect of fenofribate against cardiac hypertrophy. Methods Abdominal aorta coarctation (AAC)-induced hypertensive rats were constructed to observe the effect of fenofribate on left ventricular hypertrophy. Results Fenofribate could inhibit left ventricular hypertrophy in AAC-induced hypertensive rats. Compared with sham group, the mRNA and protein levels of NADPH oxidase Nox4 were significantly elevated in left ventricular tissue of AAC group; compared with AAC group, fenofribate reduced the mRNA and protein levels of NADPH oxidase Nox4 in left ventricular tissue in a dose-dependent manner.Conclusion Reducing NADPH oxidase Nox4 expression could be a crucial mechanism of fenofribate against hypertension-induced cardiac hypertrophy. It will provide further theoretical and experimental support for fenofribate curing hypertension- induced myocardial hypertrophy.

    Reference
    Cited by
Get Citation

ZENG Si-Yu, ZHOU Chang-Hua, LAN Shu-Min, LU Hui-Qin, CHEN Yan, YAN Qiu-Jiang, YAN Peng-Ke, LIU Pei-Qing. NADPH Oxidase Nox4 Regulates the Protective Effect of Fenofribate Against Cardiac Hypertrophy[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(6):557-560.

Copy
Share
Article Metrics
  • Abstract:1141
  • PDF: 356
  • HTML: 0
  • Cited by: 0
History
  • Received:November 05,2015
  • Revised:December 24,2015
  • Online: June 30,2016
Article QR Code